Sage Therapeutics Stock Soars 35% After Sale to Supernus Pharmaceuticals. What We Know.

Jun 16, 2025 - 13:14
 0
Sage Therapeutics Stock Soars 35% After Sale to Supernus Pharmaceuticals. What We Know.